Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade

Isotype:
IgG4, Kappa

€120.00

100ug + 120 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb
Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb binds to CD137 Recombinant Protein in Indirect ELISA Assay

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade

Product name Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade
Source CAS 934823-49-1
Species Homo sapiens
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Urelumab,BMS-663513,TNFRSF9, CD137 ,anti-TNFRSF9, CD137
Reference PX-TA1265
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody
Product name Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade
Source CAS 934823-49-1
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Urelumab,BMS-663513,TNFRSF9, CD137 ,anti-TNFRSF9, CD137
Reference PX-TA1265
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody

General information on Anti-TNFRSF9/CD137 [Homo sapiens] (Urelumab) Monoclonal Antibody

Urelumab is a human antibody targeting CD137. Urelumab has been investigated for the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, Cancer – Solid Tumors and B-Cell Non-Hodgkin’s Lymphoma.

SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb

SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb binds to CD137 Recombinant Protein in Indirect ELISA Assay

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb binds to CD137 Recombinant Protein in Indirect ELISA Assay

Immobilized CD137 Recombinant Protein (cat. No.PX-P4107) at 0.5µg/mL (100µL/well) can bind to Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb (cat. No.PX-TA1265) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products